⌘K

Login Start Free

Home/Filings/4/0001209191-06-002538

4//SEC Filing

Brann Mark R 4

Accession 0001209191-06-002538

CIK 0001070494other

View on SEC.gov Company Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 7:10 PM ET

Size

5.7 KB

Accession

0001209191-06-002538

Insider Transaction Report

Form 4

Period: 2006-01-06

ACADIA PHARMACEUTICALS INCACAD

DirectorPresident & CSO

Transactions

Sale
Common Stock
2006-01-06$10.08/sh−6,000$60,480→ 377,756 total(indirect: By Trust)

Holdings

Common Stock
52,593

Footnotes (1)

[F1]The sales reported in this Form 4 were effected pursuant to an existing sales plan established under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Documents

1 file

4
bsd15962_bsd2mb.xmlPrimary
MAIN DOCUMENT DESCRIPTION

Issuer

ACADIA PHARMACEUTICALS INC

CIK 0001070494

Entity typeother

Related Parties

1

filerCIK 0001291968

Filing Metadata

Form type: 4
Filed: Jan 5, 7:00 PM ET
Accepted: Jan 6, 7:10 PM ET
Size: 5.7 KB

View on SEC.gov